New Memorial Sloan Kettering Study: Symptom monitoring improves overall survival rates and quality of life for cancer patients.

PGHD in the News

New Memorial Sloan Kettering Study: Symptom monitoring improves overall survival rates and quality of life for cancer patients.

Click here to read the results in JAMA.

Also covered on NBC Nightly News below:

 

 

 

  

TapCloudSmallLogo.png

About TapCloud

TapCloud helps patients and their doctors communicate crucial information in order to achieve better health outcomes - to reduce readmissions, manage utilization, and improve patient satisfaction. TapCloud’s proprietary platform combines cutting-edge mobile technology and personalized services in order to help patients and their doctors manage chronic conditions, assess treatment or medication effectiveness, and improve at-home recovery after an invasive surgery. The platform spans over 90 different health conditions. 

TapCloud Media Contact:

David Bardach

dbardach@tapcloud.com

+1-312-371-5111

###